<?xml version="1.0" encoding="UTF-8"?>
<p id="p0600">Most studies with Arbidol use 200 mg/3*day
 <xref rid="b0815" ref-type="bibr">163</xref>, 
 <xref rid="b1445" ref-type="bibr">289</xref>, 
 <xref rid="b1450" ref-type="bibr">290</xref> following the Chinese guidelines. Previous investigations on the pharmacokinetics of Arbidol in healthy Chinese patients showed that a single 800 mg oral dose is sufficient for Cmax de ∼4,1 μM.
 <xref rid="b1460" ref-type="bibr">
  <sup>292</sup>
 </xref> This value was obtained through 
 <italic>in-vitro</italic> assays that pointed the drug as effective and promising against SARS-CoV-2. Hence, clinical trials are still necessary to confirm the efficacy of Arbidol at elevated doses to treat COVID-19.
 <xref rid="b1460" ref-type="bibr">
  <sup>292</sup>
 </xref>
</p>
